Index

• Pages: 145-150

145

Index

510(k) process, 54, 55

Abbreviated New Drug Application

(ANDA), 36

admissibility, of experts, 128–134

Adverse Event Reports (AERs), 36

affidavit of merit, 6

Agency for Healthcare Research and

Quality (AHRQ), 101

AHR Q. See Agency for Healthcare

Research and Quality (AHRQ)

Alabama, noneconomic damages in, 109

Alaska, noneconomic damages in, 109

ANDA. See Abbreviated New Drug

Application (ANDA)

arbitration agreements, 17–21

authority, arbitration and, 19

bed sores, 28–29

breach of warranty, 44–45, 59–62

budgeting, 23–24

business advice, privilege and, 87

California

noneconomic damages in, 109

recovery of medical expenses in,

106–107

capacity, arbitration and, 19

caps, damage, 78–80

care, as source of liability, 24–32

care plan, 27

causation

experts and, 121, 131

in medical device litigation, 64–65

CDER. See Center for Drug Evaluation

and Research (CDER)

CDRH. See Center for Devices and

Radiologic Health (CDRH)

Center for Devices and Radiologic

Health (CDRH), 35

Center for Drug Evaluation and

Research (CDER), 35

Centers for Medicare & Medicaid

Services (CMS)

regulation of long-term care

arbitration agreements, 21

surveys, 22–23

certificate of good faith, 6

certificates of medical merit, 81–82

class actions, medical device litigation

and, 67–68

Class I medical devices, 53–54

Class II medical devices, 54

Class III medical devices, 54

CMS. See Centers for Medicare &

Medicaid Services (CMS)

collateral source, 12–13

Colorado, noneconomic damages in,

109, 109 n.25

companionship, loss of, 113–114

comparative negligence, 116–117

Conditional Transfer Order (CTO), 51

confidentiality, as nursing facility

resident right, 25

consortium, loss of, 113–114

constitutionality, of state law caps on

noneconomic damages,

111–112

kra57974_complete.indd 145 1/18/21 8:15 AM